These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15649196)

  • 1. A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis.
    Nassiri-Kashani M; Firooz A; Khamesipour A; Mojtahed F; Nilforoushzadeh M; Hejazi H; Bouzari N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):80-3. PubMed ID: 15649196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study.
    Momeni AZ; Jalayer T; Emamjomeh M; Bashardost N; Ghassemi RL; Meghdadi M; Javadi A; Aminjavaheri M
    Arch Dermatol; 1996 Jul; 132(7):784-6. PubMed ID: 8678570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.
    Asilian A; Davami M
    Clin Exp Dermatol; 2006 Sep; 31(5):634-7. PubMed ID: 16780497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major.
    Alrajhi AA; Ibrahim EA; De Vol EB; Khairat M; Faris RM; Maguire JH
    N Engl J Med; 2002 Mar; 346(12):891-5. PubMed ID: 11907288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind, randomised placebo controlled trial of rifampicin with omeprazole in the treatment of human cutaneous leishmaniasis.
    Kochar DK; Saini G; Kochar SK; Sirohi P; Bumb RA; Mehta RD; Purohit SK
    J Vector Borne Dis; 2006 Dec; 43(4):161-7. PubMed ID: 17175700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran.
    Mohebali M; Fotouhi A; Hooshmand B; Zarei Z; Akhoundi B; Rahnema A; Razaghian AR; Kabir MJ; Nadim A
    Acta Trop; 2007 Jul; 103(1):33-40. PubMed ID: 17586452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous leishmaniasis: successful treatment with itraconazole.
    Consigli J; Danielo C; Gallerano V; Papa M; Guidi A
    Int J Dermatol; 2006 Jan; 45(1):46-9. PubMed ID: 16426375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, double-blind, controlled clinical trial.
    Firooz A; Khatami A; Khamesipour A; Nassiri-Kashani M; Behnia F; Nilforoushzadeh M; Pazoki-Toroudi H; Dowlati Y
    J Drugs Dermatol; 2005; 4(1):73-9. PubMed ID: 15696988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.
    Sadeghian G; Nilforoushzadeh MA
    Int J Dermatol; 2006 Jul; 45(7):819-21. PubMed ID: 16863518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.
    Wortmann G; Miller RS; Oster C; Jackson J; Aronson N
    Clin Infect Dis; 2002 Aug; 35(3):261-7. PubMed ID: 12115091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of head and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1 week with placebo.
    Svejgaard El; Larsen PØ; Deleuran M; Ternowitz T; Roed-Petersen J; Nilsson J
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):445-9. PubMed ID: 15196159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial.
    Reithinger R; Mohsen M; Wahid M; Bismullah M; Quinnell RJ; Davies CR; Kolaczinski J; David JR
    Clin Infect Dis; 2005 Apr; 40(8):1148-55. PubMed ID: 15791515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.
    Salmanpour R; Handjani F; Nouhpisheh MK
    J Dermatolog Treat; 2001 Sep; 12(3):159-62. PubMed ID: 12243707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Itraconazole in the treatment of New World mucocutaneous leishmaniasis.
    Calvopina M; Guevara AG; Armijos RX; Hashiguchi Y; Davidson RN; Cooper PJ
    Int J Dermatol; 2004 Sep; 43(9):659-63. PubMed ID: 15357745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miltefosine for new world cutaneous leishmaniasis.
    Soto J; Arana BA; Toledo J; Rizzo N; Vega JC; Diaz A; Luz M; Gutierrez P; Arboleda M; Berman JD; Junge K; Engel J; Sindermann H
    Clin Infect Dis; 2004 May; 38(9):1266-72. PubMed ID: 15127339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of New World cutaneous leishmaniasis with miltefosine.
    Soto J; Berman J
    Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S34-40. PubMed ID: 16930649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole in the treatment of cutaneous leishmaniasis.
    Firooz A; Khatami A; Dowlati Y
    Int J Dermatol; 2006 Dec; 45(12):1446-7. PubMed ID: 17184256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.